| Description | Flerobuterol is a β adrenergic receptor agonist potentially for the treatment of major depressive disorder. Flerobuterol enhances serotonergic neurotransmission. Flerobuterol acutely increases 5-HT synthesis, in part, through an elevation of brain Trp availability. |
| Synonyms | CRL-40996, CRL40996, CRL 40996, Flerobuterol hydrochloride |
| molecular weight | 247.74 |
| Molecular formula | C12H19ClFNO |
| CAS | 82101-08-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Morin D, Sapena R, Tillement JP, Urien S. Evidence for different interactions between beta(1)- and beta(2)-adrenoceptor subtypes with adenylyl cyclase in the rat brain: a concentration-response study using forskolin. Pharmacol Res. 2000 Apr;41(4):435-43. PubMed PMID: 10704268. 2. Tsuiki K, Blier P, Diksic M. Effect of the beta-adrenoceptor agonist flerobuterol on serotonin synthesis in the rat brain. Biochem Pharmacol. 2000 Mar 15;59(6):673-9. PubMed PMID: 10677584. 3. Toet AE, te Biesebeek JD, Vleeming W, Wemer J, Meulenbelt J, de Wildt DJ. Reduced survival after isoprenaline/dopamine in d,l-propranolol intoxicated rats. Hum Exp Toxicol. 1996 Feb;15(2):120-8. PubMed PMID: 8645502. 4. Zini R, Morin D, Martin P, Puech AJ, Tillement JP. Interactions of flerobuterol, an antidepressant drug candidate, with beta adrenoceptors in the rat brain. J Pharmacol Exp Ther. 1991 Oct;259(1):414-22. PubMed PMID: 1681091. |